305 related articles for article (PubMed ID: 18648664)
1. Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.
Wong CC; Wong CM; Ko FC; Chan LK; Ching YP; Yam JW; Ng IO
PLoS One; 2008 Jul; 3(7):e2779. PubMed ID: 18648664
[TBL] [Abstract][Full Text] [Related]
2. Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
Wong CM; Yam JW; Ching YP; Yau TO; Leung TH; Jin DY; Ng IO
Cancer Res; 2005 Oct; 65(19):8861-8. PubMed ID: 16204057
[TBL] [Abstract][Full Text] [Related]
3. DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.
Tripathi V; Popescu NC; Zimonjic DB
Oncogene; 2014 Feb; 33(6):724-33. PubMed ID: 23376848
[TBL] [Abstract][Full Text] [Related]
4. RhoE is frequently down-regulated in hepatocellular carcinoma (HCC) and suppresses HCC invasion through antagonizing the Rho/Rho-kinase/myosin phosphatase target pathway.
Ma W; Wong CC; Tung EK; Wong CM; Ng IO
Hepatology; 2013 Jan; 57(1):152-61. PubMed ID: 22829315
[TBL] [Abstract][Full Text] [Related]
5. Endosomes generate localized Rho-ROCK-MLC2-based contractile signals via Endo180 to promote adhesion disassembly.
Sturge J; Wienke D; Isacke CM
J Cell Biol; 2006 Oct; 175(2):337-47. PubMed ID: 17043135
[TBL] [Abstract][Full Text] [Related]
6. Proplatelet formation is regulated by the Rho/ROCK pathway.
Chang Y; Auradé F; Larbret F; Zhang Y; Le Couedic JP; Momeux L; Larghero J; Bertoglio J; Louache F; Cramer E; Vainchenker W; Debili N
Blood; 2007 May; 109(10):4229-36. PubMed ID: 17244674
[TBL] [Abstract][Full Text] [Related]
7. Increase in cell motility by carbon ion irradiation via the Rho signaling pathway and its inhibition by the ROCK inhibitor Y-27632 in lung adenocarcinoma A549 cells.
Murata K; Noda SE; Oike T; Takahashi A; Yoshida Y; Suzuki Y; Ohno T; Funayama T; Kobayashi Y; Takahashi T; Nakano T
J Radiat Res; 2014 Jul; 55(4):658-64. PubMed ID: 24659807
[TBL] [Abstract][Full Text] [Related]
8. Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation.
Serizawa N; Tian J; Fukada H; Baghy K; Scott F; Chen X; Kiss Z; Olson K; Hsu D; Liu FT; Török NJ; Zhao B; Jiang JX
Lab Invest; 2015 Oct; 95(10):1145-56. PubMed ID: 26146960
[TBL] [Abstract][Full Text] [Related]
9. Blockade of ROCK inhibits migration of human primary keratinocytes and malignant epithelial skin cells by regulating actomyosin contractility.
Srinivasan S; Das S; Surve V; Srivastava A; Kumar S; Jain N; Sawant A; Nayak C; Purwar R
Sci Rep; 2019 Dec; 9(1):19930. PubMed ID: 31882703
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts.
Totsukawa G; Yamakita Y; Yamashiro S; Hartshorne DJ; Sasaki Y; Matsumura F
J Cell Biol; 2000 Aug; 150(4):797-806. PubMed ID: 10953004
[TBL] [Abstract][Full Text] [Related]
11. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor activates the Rho GTPase-activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A.
Ravi A; Kaushik S; Ravichandran A; Pan CQ; Low BC
J Biol Chem; 2015 Feb; 290(7):4149-62. PubMed ID: 25525271
[TBL] [Abstract][Full Text] [Related]
13. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function.
Chan LK; Ko FC; Ng IO; Yam JW
PLoS One; 2009; 4(5):e5572. PubMed ID: 19440389
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid induces focal adhesion assembly through Rho/Rho-associated kinase pathway in human ovarian cancer cells.
Sawada K; Morishige Ki; Tahara M; Ikebuchi Y; Kawagishi R; Tasaka K; Murata Y
Gynecol Oncol; 2002 Dec; 87(3):252-9. PubMed ID: 12468322
[TBL] [Abstract][Full Text] [Related]
15. The tumor suppressor protein DLC1 maintains protein kinase D activity and Golgi secretory function.
Jensch A; Frey Y; Bitschar K; Weber P; Schmid S; Hausser A; Olayioye MA; Radde NE
J Biol Chem; 2018 Sep; 293(37):14407-14416. PubMed ID: 30045871
[TBL] [Abstract][Full Text] [Related]
16. Deficient E-cadherin adhesion in C57BL/6J-Min/+ mice is associated with increased tyrosine kinase activity and RhoA-dependent actomyosin contractility.
Carothers AM; Javid SH; Moran AE; Hunt DH; Redston M; Bertagnolli MM
Exp Cell Res; 2006 Feb; 312(4):387-400. PubMed ID: 16368433
[TBL] [Abstract][Full Text] [Related]
17. The role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancer.
Sabbir MG; Prieditis H; Ravinsky E; Mowat MR
PLoS One; 2012; 7(7):e40302. PubMed ID: 22792269
[TBL] [Abstract][Full Text] [Related]
18. Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms.
Birukova AA; Smurova K; Birukov KG; Usatyuk P; Liu F; Kaibuchi K; Ricks-Cord A; Natarajan V; Alieva I; Garcia JG; Verin AD
J Cell Physiol; 2004 Oct; 201(1):55-70. PubMed ID: 15281089
[TBL] [Abstract][Full Text] [Related]
19. Multiple downstream signalling pathways from ROCK, a target molecule of Rho small G protein, in reorganization of the actin cytoskeleton in Madin-Darby canine kidney cells.
Takaishi K; Matozaki T; Nakano K; Takai Y
Genes Cells; 2000 Nov; 5(11):929-936. PubMed ID: 11122380
[TBL] [Abstract][Full Text] [Related]
20. DEK depletion negatively regulates Rho/ROCK/MLC pathway in non-small cell lung cancer.
Wang J; Sun L; Yang M; Luo W; Gao Y; Liu Z; Qiu X; Wang E
J Histochem Cytochem; 2013 Jul; 61(7):510-21. PubMed ID: 23571382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
